欧洲流式细胞仪市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲流式细胞仪市场 – 行业趋势和 2030 年预测

  • Medical Devices
  • Published Report
  • Apr 2023
  • Europe
  • 350 页面
  • 桌子數: 188
  • 图号: 39

Europe Flow Cytometry Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 1,265.49 Million
Diagram Market Size (Forecast Year)
USD 2,563.23 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Thermo Fisher Scientific
  • BD
  • Agilent Technologies
  • Sartorius AG
  • Bio-Rad Laboratories

>欧洲流式细胞术市场,按产品(流式细胞术仪器、试剂和消耗品、软件、配件和服务)、技术(基于细胞的流式细胞术和基于珠子的流式细胞术)、应用(研究应用、临床应用和工业应用)、最终用户(学术和研究机构、医院、制药和生物技术公司、临床测试实验室、血库等)、分销渠道(直接招标和零售销售)划分 - 行业趋势和预测到 2030 年。

流式细胞仪市场

欧洲流式细胞仪市场分析与见解

欧洲流式细胞仪市场受到多种因素的推动,例如慢性病患病率不断上升、流式细胞仪市场对新技术的需求不断增长(这增加了其需求),以及研发投资不断增加(这导致市场增长)。目前,发达国家和新兴国家的医疗保健支出都有所增加,这有望为制造商创造竞争优势,以开发新的创新型流式细胞仪市场。然而,流式细胞仪仪器的高成本预计将抑制欧洲流式细胞仪市场的增长。

流式细胞仪市场

流式细胞仪市场

欧洲流式细胞仪市场报告提供了市场份额、新发展和产品线分析的详细信息,国内和本地市场参与者的影响,分析了新兴收入来源、市场法规变化、产品批准、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情景,请联系我们获取分析师简报。我们的团队将帮助您创建收入影响解决方案,以实现您的预​​期目标。各地区发展中国家零售单位的可扩展性和业务扩展以及与供应商合作安全分销机器和药品是推动预测期内市场需求的主要驱动力。

预计欧洲流式细胞仪市场将在 2023 年至 2030 年的预测期内实现市场增长。Data Bridge Market Research 分析称,在 2023 年至 2030 年的预测期内,该市场将以 9.3% 的复合年增长率增长,预计到 2030 年将从 2022 年的 12.6549 亿美元达到 25.6323 亿美元。

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2015-2020)

定量单位

收入(百万美元)

涵盖的领域

按产品(流式细胞仪、试剂和耗材、软件、配件和服务)、技术(基于细胞的流式细胞仪和基于珠子的流式细胞仪)、应用(研究应用、临床应用和工业应用)、最终用户(学术和研究机构、医院、制药和生物技术公司、临床检测实验室、血库等)、分销渠道(直接招标和零售)

覆盖国家

德国、法国、英国、意大利、西班牙、俄罗斯、荷兰、瑞士、土耳其、比利时、欧洲其他地区

涵盖的市场参与者

Thermo Fisher Scientific Inc.(美国)、BD(美国)、Agilent Technologies, Inc.(美国)、Sartorius AG(德国)、Bio-Rad Laboratories, Inc.(美国)、Sysmex Corporation(日本)、Coherent Corp.(美国)、Beckman Coulter, Inc.(Danaher Corporation 的子公司)(美国)、BIOMÉRIEUX(法国)、Merck KGaA(德国)、Sony Biotechnology Inc.(美国)、Apogee Flow Systems Ltd.(英国)、Bay bioscience Co., Ltd.(日本)、NeoGenomics Laboratories(美国)、Enzo Biochem Inc.(美国)、ORLFO Technologies、CytoBuoy bv、Elabscience Biotechnology Inc.、Takara Bio Inc.(美国)、Union Biometrica, Inc.(美国)、Nexcelom Bioscience LLC(美国)等

市场定义

流式细胞术是从异源细胞混合物中筛选细胞的关键过程,可用于细胞分选、计数、蛋白质再生和工程。流式细胞术的常见用途包括分析细胞表面和细胞内分子表达、表征和定义异源细胞群中的各种细胞类型、评估分离亚群的纯度以及测量细胞大小和体积。它可以同时检查单个细胞的多个参数。流式细胞仪使用激光产生光,随后光被样本细胞散射,由检测器记录,并转换成信号进行分析和测量。

不断增长的创新和技术、市场参与者数量的增加以及新产品的推出也推动了欧洲流式细胞仪市场的增长。

欧洲流式细胞仪市场动态

驱动程序

  • 慢性病患病率上升

慢性病的患病率和发病率不断上升,可能会通过专注于细胞计数设备来推动市场增长。疾病发病率的上升导致欧洲市场增长,因为许多公司都在投资研发。这导致对通过快速准确的技术诊断疾病的进步的需求大幅增加。

例如,

  • 2021年1月,根据世界卫生组织的报告,癌症成为2020年死亡的主要原因,约有1000万人,其中最常见的是乳腺癌(226万)、肺癌(221万)、结肠和直肠癌(193万);前列腺癌(141万)、皮肤癌(120万)和胃癌(109万)

因此,这增加了流式细胞仪市场的需求。

  • 流式细胞仪的应用日益广泛

细胞计数仪器的技术发展正在不断进步,它结合了多种新技术,以提供高分辨率和灵敏度来量化新的细胞实体。

免疫表型分析不仅对急性白血病、慢性淋巴增生性疾病和恶性淋巴瘤的初步诊断和分类很重要,而且对其治疗也很重要。流式细胞术可用作一种灵敏的检测方法,用于追踪患者化疗或移植后的病情好转情况,并检测微小残留病 (MRD)。

例如,

  • 2022 年 1 月,欧洲医疗技术公司 Becton, Dickinson and Company 宣布与欧洲分子生物学实验室 (EMBL) 合作开展的一项研究,并发表了 BD 在流式细胞术方面的新创新,该创新增加了荧光成像和基于图像的去库处理功能,可根据每个细胞的视觉细节(而不是存在的生物标志物的类型或数量)以极高的速度对单个细胞进行分类。这种新方法有可能彻底改变免疫学、细胞生物学和基因组学研究,并推动开发新的基于细胞的疗法

 因此,这有望成为流式细胞术市场增长的推动力。

机会

  • 干细胞研究的增长和 DNA 重组技术的获得

干细胞研究的增长包括快速增加细胞增殖或分化的因素,其中可利用基于激光的细胞术来分析干细胞的特征。

流式细胞术评估此阶段并检测其中的细胞分布,以计算具有分数 DNA 含量的凋亡细胞频率。

例如,

  • 知名公司Thermo Fisher Scientific Inc.在生产线上有Alexa Fluor 488流式细胞术检测试剂盒,用于检测细胞的DNA复制和增殖

因此,这些机会有望推动该地区对流式细胞仪的需求。

  • 流式细胞术技术在研究和学术领域的应用日益增多

流式细胞术是一种先进的技术,可以以每秒数千个细胞的速度测量悬浮液中的单个细胞和其他颗粒。流式细胞术已扩展到环境调查、细胞外囊泡分析,并能够使用多达 30 种不同的参数进行更广泛的分析。它最常用于免疫学领域。

例如,

  • 2018 年 12 月,News-Medical.net 文章指出,将荧光标记的单克隆抗体与流式细胞术相结合是癌症研究人员的常用方法。同样,经过十多年的广泛研究,基于图像的高通量流式细胞术现已被科学研究和学术界接受并广泛使用,特别是在癌症生物学领域

限制/挑战

  • 流式细胞仪成本高

流式细胞仪有各种形状和尺寸,但台式仪器是最常见的。它们提供最佳的数据分析、使用便利性以及各种系统的升级和选项,所有这些都旨在解决定制分离、细胞/颗粒分选、探索性细胞分析和其他问题。所有流式细胞仪都具有三个共同的组件 - 流体、光学和电子/信息学。

流式细胞仪非常昂贵,特别是考虑到维修和维护相关的成本。

COVID-19 对欧洲流式细胞仪市场的影响

由于疾病诊断和研究目的,COVID-19 对市场产生了积极影响,从而增加了这一时期对流式细胞仪的需求。

近期发展

  • 2022 年 1 月,索尼生物技术公司推出了一种新型封闭细胞分离系统 CGX10,用于符合 GMP 的细胞分选应用。借助这一举措,该公司有望获得新的增长机会。这种技术进步将带来成本效益、更高的准确性和便携性,并可能创造未来的增长机会。

欧洲流式细胞仪市场范围

欧洲流式细胞仪市场细分为产品、技术、应用、最终用户和分销渠道。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,以便做出战略决策,确定核心市场应用。

产品

  • 试剂和耗材
  • 流式细胞仪
  • 配件
  • 服务
  • 软件

根据产品,欧洲流式细胞仪市场分为流式细胞仪仪器、试剂和耗材、软件、配件和服务。

技术

  • 基于细胞的流式细胞术
  • 基于珠子的流式细胞术

根据技术,欧洲流式细胞术市场分为基于细胞的流式细胞术和基于珠子的流式细胞术。

应用

  • 研究应用
  • 临床应用
  • 工业应用

根据应用,欧洲流式细胞仪市场分为研究应用、临床应用和工业应用。

最终用户

  • 制药和生物技术公司
  • 学术及研究机构
  • 医院
  • 临床检测实验室
  • 血库
  • 其他的

根据最终用户,欧洲流式细胞仪市场分为学术和研究机构、医院、制药和生物技术公司、临床检测实验室、血库等。

分销渠道

  • 零售
  • 直接招标

根据分销渠道,欧洲流式细胞仪市场分为零售和直接招标。

流式细胞仪市场

欧洲流式细胞仪市场区域分析/见解

对欧洲流式细胞仪市场进行了分析,并按国家、类型、技术和最终用户提供了市场规模洞察和趋势,如上所述。

由于德国开展的临床试验数量众多,且该国对健康问题的认识不断提高,预计德国将主导欧洲流式细胞仪市场。他们在市场份额和市场收入方面占据流式细胞仪市场的主导地位,并将在预测期内继续保持主导地位。

报告的国家部分还提供了影响单个市场因素和市场法规变化的信息,这些因素和变化会影响市场的当前和未来趋势。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测单个国家市场情况的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了欧洲品牌的存在和可用性以及它们因本土和国内品牌的激烈竞争而面临的挑战以及销售渠道的影响。

竞争格局和欧洲流式细胞仪市场份额分析

欧洲流式细胞仪市场竞争格局提供了有关竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、欧洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对欧洲流式细胞仪市场的关注有关。

欧洲流式细胞仪市场的一些主要参与者包括赛默飞世尔科技公司 (Thermo Fisher Scientific Inc.)、BD、安捷伦科技公司 (Agilent Technologies, Inc.)、赛多利斯公司 (Sartorius AG)、Bio-Rad Laboratories, Inc.、Sysmex Corporation、Coherent Corp.、贝克曼库尔特公司 (Beckman Coulter, Inc.)(丹纳赫集团的子公司)、bioMérieux SA、默克公司 (Merck KGaA)、索尼生物技术公司 (Sony Biotechnology Inc.)、Apogee Flow Systems Ltd.、Bay bioscience Co., Ltd.、NeoGenomics Laboratories、Enzo Biochem Inc.、ORLFO Technologies、CytoBuoy bv、Elabscience Biotechnology Inc.、Takara Bio Inc.、Union Biometrica, Inc. 和 Nexcelom Bioscience LLC 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE FLOW CYTOMETRY MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT SEGMENT LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES

4.2 PESTEL ANALYSIS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISING PREVALENCE OF CHRONIC DISEASES

5.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS

5.1.3 INCREASE IN USE OF FLOW CYTOMETRY IN DRUG DISCOVERY

5.1.4 GROWTH IN STEM CELL RESEARCH AND ACQUISITION OF RECOMBINATION OF DNA TECHNOLOGIES

5.2 RESTRAINTS

5.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS

5.2.2 LIMITATIONS OF FLOW CYTOMETRY

5.2.3 LACK OF SKILLED PROFESSIONALS

5.3 OPPORTUNITIES

5.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA

5.3.2 DEVELOPMENT IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES

5.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS

5.3.4 DEVELOPING A PIPELINE OF STEM CELL RESEARCH

5.4 CHALLENGES

5.4.1 DIFFICULTY IN THE DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS

5.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT

6 EUROPE FLOW CYTOMETRY MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 REAGENTS AND CONSUMABLES

6.2.1 DYE

6.2.2 ANTIBODIES

6.2.3 BEADS

6.2.4 OTHERS

6.3 FLOW CYTOMETRY INSTRUMENTS

6.3.1 CELL ANALYZERS

6.3.1.1 CELL ANALYZERS, BY TYPE

6.3.1.1.1 IMAGING FLOW CYTOMETERS

6.3.1.1.2 NON-IMAGING FLOW CYTOMETERS

6.3.1.2 CELL ANALYZERS, BY MODALITY

6.3.1.2.1 BENCHTOP

6.3.1.2.2 STANDALONE

6.3.2 CELL SORTERS

6.3.2.1 BENCHTOP

6.3.2.2 STANDALONE

6.4 ACCESSORIES

6.4.1 FILTERS

6.4.2 DETECTORS

6.4.3 OTHERS

6.5 SERVICES

6.6 SOFTWARE

7 EUROPE FLOW CYTOMETRY MARKET, BY TECHNOLOGY

7.1 OVERVIEW

7.2 CELL-BASED FLOW CYTOMETRY

7.3 BEAD-BASED FLOW CYTOMETRY

8 EUROPE FLOW CYTOMETRY MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 RESEARCH APPLICATIONS

8.2.1 CELL CYCLE ANALYSIS

8.2.2 CELL SORTING/SCREENING

8.2.3 CELL TRANSFECTION/VIABILITY

8.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY

8.2.4.1 DRUG DISCOVERY

8.2.4.2 STEM CELL RESEARCH

8.2.4.3 IN VITRO TOXICITY TESTING

8.2.5 IMMUNOLOGY

8.2.6 APOPTOSIS

8.2.7 CELL COUNTING

8.2.8 OTHERS

8.3 CLINICAL APPLICATIONS

8.3.1 HAEMATOLOGY

8.3.2 CANCER

8.3.3 IMMUNODEFICIENCY DISEASES

8.3.4 ORGAN TRANSPLANTATION

8.3.5 OTHER CLINICAL APPLICATION

8.4 INDUSTRIAL APPLICATIONS

9 EUROPE FLOW CYTOMETRY MARKET, BY END USER

9.1 OVERVIEW

9.2 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES

9.3 ACADEMIC & RESEARCH INSTITUTES

9.4 HOSPITALS

9.5 CLINICAL TESTING LABORATORIES

9.6 BLOOD BANK

9.7 OTHERS

10 EUROPE FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 RETAIL SALES

10.3 DIRECT TENDERS

11 EUROPE FLOW CYTOMETRY MARKET, BY GEOGRAPHY

11.1 EUROPE

11.1.1 GERMANY

11.1.2 FRANCE

11.1.3 U.K.

11.1.4 ITALY

11.1.5 SPAIN

11.1.6 RUSSIA

11.1.7 NETHERLANDS

11.1.8 SWITZERLAND

11.1.9 TURKEY

11.1.10 BELGIUM

11.1.11 REST OF EUROPE

12 EUROPE FLOW CYTOMETRY MARKET, COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 SWOT ANALYSIS

14 COMPANY PROFILE

14.1 THERMO FISHER SCIENTIFIC INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENTS

14.2 BD

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENT

14.2.5.1 COLLABORATION

14.3 AGILENT TECHNOLOGIES, INC.

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 SARTORIUS AG

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENT

14.5 NEXCELOM BIOSCIENCE LLC

14.5.1 COMPANY SNAPSHOT

14.5.2 PRODUCT PORTFOLIO

14.5.3 RECENT DEVELOPMENT

14.5.4 COMPANY SHARE ANALYSIS

14.6 APOGEE FLOW SYSTEMS LTD.

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENT

14.7 BAY BIOSCIENCE CO., LTD.

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENT

14.8 BIOMÉRIEUX

14.8.1 COMPANY SNAPSHOT

14.8.2 REVENUE ANALYSIS

14.8.3 PRODUCT PORTFOLIO

14.8.4 RECENT DEVELOPMENT

14.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION)

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT DEVELOPMENTS

14.9.4.1 ACQUISITION

14.9.4.2 PRODUCT LAUNCH

14.1 BENNUBIO INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENT

14.11 BIOLEGEND, INC.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.12 BIO-RAD LABORATORIES, INC.

14.12.1 COMPANY SNAPSHOT

14.12.2 REVENUE ANALYSIS

14.12.3 PRODUCT PORTFOLIO

14.12.4 RECENT DEVELOPMENT

14.13 CELL SIGNALING TECHNOLOGY, INC.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 CELLKRAFT BIOTECH PVT. LTD

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENT

14.15 CYTEK BIOSCIENCES

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENTS

14.15.3.1 PRODUCT LAUNCH

14.15.3.2 ACQUISITION

14.16 CYTOBUOY B.V.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENT

14.17 CYTONOME/ST, LLC

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.18 COHERENT CORP.

14.18.1 COMPANY SNAPSHOT

14.18.2 REVENUE ANALYSIS

14.18.3 PRODUCT PORTFOLIO

14.18.4 RECENT DEVELOPMENTS

14.18.4.1 Announcement

14.18.4.2 PRODUCT LAUNCH

14.18.4.3 AWARDS

14.18.5 RECENT DEVELOPMENT

14.19 ELABSCIENCE BIOTECHNOLOGY INC.

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENT

14.2 ENZO BIOCHEM INC.

14.20.1 COMPANY SNAPSHOT

14.20.2 REVENUE ANALYSIS

14.20.3 PRODUCT PORTFOLIO

14.20.4 RECENT DEVELOPMENT

14.21 IKEDA SCIENTIFIC CO., LTD.

14.21.1 COMPANY SNAPSHOT

14.21.2 PRODUCT PORTFOLIO

14.21.3 RECENT DEVELOPMENT

14.22 MERCK KGAA

14.22.1 COMPANY SNAPSHOT

14.22.2 REVENUE ANALYSIS

14.22.3 PRODUCT PORTFOLIO

14.22.4 RECENT DEVELOPMENT

14.23 MILTENYI BIOTEC

14.23.1 COMPANY SNAPSHOT

14.23.2 PRODUCT PORTFOLIO

14.23.3 RECENT DEVELOPMENT

14.23.3.1 PRODUCT LAUNCH

14.24 NANOCELLECT BIOMEDICAL

14.24.1 COMPANY SNAPSHOT

14.24.2 PRODUCT PORTFOLIO

14.24.3 RECENT DEVELOPMENTS

14.25 NEOGENOMICS LABORATORIES

14.25.1 COMPANY SNAPSHOT

14.25.2 REVENUE ANALYSIS

14.25.3 PRODUCT PORTFOLIO

14.25.4 RECENT DEVELOPMENT

14.26 ON-CHIP BIOTECHNOLOGIES CO., LTD. CORPORATION

14.26.1 COMPANY SNAPSHOT

14.26.2 PRODUCT PORTFOLIO

14.26.3 RECENT DEVELOPMENTS

14.27 ORFLO TECHNOLOGIES

14.27.1 COMPANY SNAPSHOT

14.27.2 PRODUCT PORTFOLIO

14.27.3 RECENT DEVELOPMENT

14.28 Q2 SOLUTION

14.28.1 COMPANY SNAPSHOT

14.28.2 REVENUE ANALYSIS

14.28.3 SERVICE PORTFOLIO

14.28.4 RECENT DEVELOPMENT

14.29 SONY BIOTECHNOLOGY INC.

14.29.1 COMPANY SNAPSHOT

14.29.2 PRODUCT PORTFOLIO

14.29.3 RECENT DEVELOPMENT

14.3 STRATEDIGM, INC

14.30.1 COMPANY SNAPSHOT

14.30.2 PRODUCT PORTFOLIO

14.30.3 RECENT DEVELOPMENT

14.31 SYSMEX CORPORATION

14.31.1 COMPANY SNAPSHOT

14.31.2 REVENUE ANALYSIS

14.31.3 PRODUCT PORTFOLIO

14.31.4 RECENT DEVELOPMENT

14.32 TAKARA BIO INC.

14.32.1 COMPANY SNAPSHOT

14.32.2 REVENUE ANALYSIS

14.32.3 PRODUCT PORTFOLIO

14.32.4 RECENT DEVELOPMENTS

14.33 UNION BIOMETRICA, INC.

14.33.1 COMPANY SNAPSHOT

14.33.2 PRODUCT PORTFOLIO

14.33.3 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS

表格列表

TABLE 1 EUROPE FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 2 EUROPE REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 EUROPE REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 4 EUROPE FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 5 EUROPE FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 6 EUROPE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 7 EUROPE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 8 EUROPE CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 9 EUROPE ACCESSORIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 10 EUROPE ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 11 EUROPE SERVICES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 12 EUROPE SOFTWARE IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 13 EUROPE FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 14 EUROPE CELL-BASED FLOW CYTOMETRY IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 15 EUROPE BEAD-BASED FLOW CYTOMETRY IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 16 EUROPE FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 17 EUROPE RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 18 EUROPE RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 19 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 20 EUROPE CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 21 EUROPE CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 22 EUROPE INDUSTRIAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 23 EUROPE FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 24 EUROPE PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 25 EUROPE ACADEMIC & RESEARCH INSTITUTES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 26 EUROPE HOSPITALS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 27 EUROPE CLINICAL TESTING LABORATORIES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 28 EUROPE BLOOD BANK IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 EUROPE OTHERS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 EUROPE FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 31 EUROPE RETAIL SALES IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 32 EUROPE DIRECT TENDERS IN FLOW CYTOMETRY MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 EUROPE FLOW CYTOMETRY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 34 EUROPE FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 35 EUROPE REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 36 EUROPE FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 37 EUROPE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 38 EUROPE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 39 EUROPE CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 40 EUROPE ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 41 EUROPE FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 42 EUROPE FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 43 EUROPE RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 44 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 45 EUROPE CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 46 EUROPE FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 47 EUROPE FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 48 GERMANY FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 49 GERMANY REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 50 GERMANY FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 51 GERMANY CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 52 GERMANY CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 53 GERMANY CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 54 GERMANY ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 55 GERMANY FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 56 GERMANY FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 57 GERMANY RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 58 GERMANY PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 59 GERMANY CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 60 GERMANY FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 61 GERMANY FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 62 FRANCE FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 63 FRANCE REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 64 FRANCE FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 65 FRANCE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 66 FRANCE CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 67 FRANCE CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 68 FRANCE ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 69 FRANCE FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 70 FRANCE FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 71 FRANCE RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 72 FRANCE PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 73 FRANCE CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 74 FRANCE FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 75 FRANCE FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 76 U.K. FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 77 U.K. REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 78 U.K. FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 79 U.K. CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 80 U.K. CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 81 U.K. CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 82 U.K. ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 83 U.K. FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 84 U.K. FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 85 U.K. RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 86 U.K. PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 87 U.K. CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 88 U.K. FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 89 U.K. FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 90 ITALY FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 91 ITALY REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 92 ITALY FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 93 ITALY CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 94 ITALY CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 95 ITALY CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 96 ITALY ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 97 ITALY FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 98 ITALY FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 99 ITALY RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 100 ITALY PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 101 ITALY CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 102 ITALY FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 103 ITALY FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 104 SPAIN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 105 SPAIN REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 106 SPAIN FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 107 SPAIN CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 108 SPAIN CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 109 SPAIN CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 110 SPAIN ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 111 SPAIN FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 112 SPAIN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 113 SPAIN RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 114 SPAIN PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 115 SPAIN CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 116 SPAIN FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 117 SPAIN FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 118 RUSSIA FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 119 RUSSIA REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 120 RUSSIA FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 121 RUSSIA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 122 RUSSIA CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 123 RUSSIA CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 124 RUSSIA ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 125 RUSSIA FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 126 RUSSIA FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 127 RUSSIA RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 128 RUSSIA PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 129 RUSSIA CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 130 RUSSIA FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 131 RUSSIA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 132 NETHERLANDS FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 133 NETHERLANDS REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 134 NETHERLANDS FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 135 NETHERLANDS CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 136 NETHERLANDS CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 137 NETHERLANDS CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 138 NETHERLANDS ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 139 NETHERLANDS FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 140 NETHERLANDS FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 141 NETHERLANDS RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 142 NETHERLANDS PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 143 NETHERLANDS CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 144 NETHERLANDS FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 145 NETHERLANDS FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 146 SWITZERLAND FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 147 SWITZERLAND REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 148 SWITZERLAND FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 149 SWITZERLAND CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 150 SWITZERLAND CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 151 SWITZERLAND CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 152 SWITZERLAND ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 153 SWITZERLAND FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 154 SWITZERLAND FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 155 SWITZERLAND RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 156 SWITZERLAND PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 157 SWITZERLAND CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 158 SWITZERLAND FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 159 SWITZERLAND FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 160 TURKEY FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 161 TURKEY REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 162 TURKEY FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 163 TURKEY CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 164 TURKEY CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 165 TURKEY CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 166 TURKEY ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 167 TURKEY FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 168 TURKEY FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 169 TURKEY RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 170 TURKEY PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 171 TURKEY CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 172 TURKEY FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 173 TURKEY FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 174 BELGIUM FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 175 BELGIUM REAGENTS AND CONSUMABLES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 176 BELGIUM FLOW CYTOMETRY INSTRUMENTS IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 177 BELGIUM CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 178 BELGIUM CELL ANALYZERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 179 BELGIUM CELL SORTERS IN FLOW CYTOMETRY MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 180 BELGIUM ACCESSORIES IN FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 181 BELGIUM FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)

TABLE 182 BELGIUM FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 183 BELGIUM RESEARCH APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 184 BELGIUM PHARMACEUTICAL AND BIOTECHNOLOGY IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 185 BELGIUM CLINICAL APPLICATIONS IN FLOW CYTOMETRY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 186 BELGIUM FLOW CYTOMETRY MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 187 BELGIUM FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 188 REST OF EUROPE FLOW CYTOMETRY MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

图片列表

FIGURE 1 EUROPE FLOW CYTOMETRY MARKET: SEGMENTATION

FIGURE 2 EUROPE FLOW CYTOMETRY MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE FLOW CYTOMETRY MARKET: DROC ANALYSIS

FIGURE 4 EUROPE FLOW CYTOMETRY MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 EUROPE FLOW CYTOMETRY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE FLOW CYTOMETRY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE FLOW CYTOMETRY MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE FLOW CYTOMETRY MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 EUROPE FLOW CYTOMETRY MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE FLOW CYTOMETRY MARKET: SEGMENTATION

FIGURE 11 INCREASING INCIDENCE AND PREVALENCE OF CHRONIC DISEASES ARE EXPECTED TO DRIVE THE EUROPE FLOW CYTOMETRY MARKET IN THE FORECAST PERIOD

FIGURE 12 THE REAGENTS AND CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE FLOW CYTOMETRY MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE FLOW CYTOMETRY MARKET

FIGURE 14 EUROPE FLOW CYTOMETRY MARKET: BY PRODUCT, 2022

FIGURE 15 EUROPE FLOW CYTOMETRY MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 16 EUROPE FLOW CYTOMETRY MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 17 EUROPE FLOW CYTOMETRY MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 18 EUROPE FLOW CYTOMETRY MARKET: BY TECHNOLOGY, 2022

FIGURE 19 EUROPE FLOW CYTOMETRY MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)

FIGURE 20 EUROPE FLOW CYTOMETRY MARKET: BY TECHNOLOGY, CAGR (2023-2030)

FIGURE 21 EUROPE FLOW CYTOMETRY MARKET: BY TECHNOLOGY, LIFELINE CURVE

FIGURE 22 EUROPE FLOW CYTOMETRY MARKET: BY APPLICATION, 2022

FIGURE 23 EUROPE FLOW CYTOMETRY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 24 EUROPE FLOW CYTOMETRY MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 25 EUROPE FLOW CYTOMETRY MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 EUROPE FLOW CYTOMETRY MARKET: BY END USER, 2022

FIGURE 27 EUROPE FLOW CYTOMETRY MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 28 EUROPE FLOW CYTOMETRY MARKET: BY END USER, CAGR (2023-2030)

FIGURE 29 EUROPE FLOW CYTOMETRY MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 EUROPE FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 31 EUROPE FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 32 EUROPE FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 33 EUROPE FLOW CYTOMETRY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 34 EUROPE FLOW CYTOMETRY MARKET: SNAPSHOT (2022)

FIGURE 35 EUROPE FLOW CYTOMETRY MARKET: BY COUNTRY (2022)

FIGURE 36 EUROPE FLOW CYTOMETRY MARKET: BY COUNTRY (2023 & 2030)

FIGURE 37 EUROPE FLOW CYTOMETRY MARKET: BY COUNTRY (2022 & 2030)

FIGURE 38 EUROPE FLOW CYTOMETRY MARKET: PRODUCT (2023-2030)

FIGURE 39 EUROPE FLOW CYTOMETRY MARKET: COMPANY SHARE 2022 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales) - Industry Trends and Forecast to 2030. .
The Europe Flow Cytometry Market size was valued at USD 1265.49 USD Million in 2022.
The Europe Flow Cytometry Market is projected to grow at a CAGR of 9.3% during the forecast period of 2023 to 2030.
The major players operating in the market include Thermo Fisher Scientific , BD, Agilent Technologies , Sartorius AG, Bio-Rad Laboratories , Sysmex Corporation, Coherent Corp., Beckman Coulter , BIOMÉRIEUX, Merck KGaA, Sony Biotechnology , Apogee Flow Systems , Bay bioscience Co. , NeoGenomics Laboratories, Enzo Biochem , ORLFO Technologies, CytoBuoy b.v., Elabscience Biotechnology , Takara Bio , Union Biometrica , Nexcelom Bioscience LLC, among others,.
The market report covers data from the Germany, France, U.K.,  Italy, Spain, Russia, Netherlands, Switzerland, Turkey,  Belgium, Rest of Europe.